Home Applications 211150 Application 211150
Type NDA
Sponsor HARMONY Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 WAKIX PITOLISANT HYDROCHLORIDE TABLET;ORAL EQ 4.45MG BASE Yes No 002 WAKIX PITOLISANT HYDROCHLORIDE TABLET;ORAL EQ 17.8MG BASE Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N211150-001 WAKIX PITOLISANT HYDROCHLORIDE EQ 4.45MG BASE TABLET / ORAL AB RLD 2019-08-14 N211150-002 WAKIX PITOLISANT HYDROCHLORIDE EQ 17.8MG BASE TABLET / ORAL AB RLD, RS 2019-08-14
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Orange Book patents# Current patent rows page 1 of 1 · 10 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N211150-001 8354430 2026-02-06 U-1101 2019-09-11 N211150-001 8354430 2026-02-06 U-1102 2019-09-11 N211150-001 8486947 2029-09-26 U-1101 2019-09-11 N211150-001 8486947 2029-09-26 U-1102 2019-09-11 N211150-001 8207197 2030-03-07 Drug substance, Drug product 2019-09-11 N211150-002 8354430 2026-02-06 U-1101 2019-09-11 N211150-002 8354430 2026-02-06 U-1102 2019-09-11 N211150-002 8486947 2029-09-26 U-1101 2019-09-11 N211150-002 8486947 2029-09-26 U-1102 2019-09-11 N211150-002 8207197 2030-03-07 Drug substance, Drug product 2019-09-11
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 10 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 84 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N211150-001 WAKIX EQ 4.45MG BASE TABLET / ORAL AB RLD 2019-08-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211150-002 WAKIX EQ 17.8MG BASE TABLET / ORAL AB RLD, RS 2019-08-14 84e616aacf4f…2026-08-18 06:07:40 2026-07 N211150-001 WAKIX EQ 4.45MG BASE TABLET / ORAL AB RLD 2019-08-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211150-002 WAKIX EQ 17.8MG BASE TABLET / ORAL AB RLD, RS 2019-08-14 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N211150-001 WAKIX EQ 4.45MG BASE TABLET / ORAL RLD 2019-08-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211150-002 WAKIX EQ 17.8MG BASE TABLET / ORAL RLD, RS 2019-08-14 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211150-001 WAKIX EQ 4.45MG BASE TABLET / ORAL RLD 2019-08-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211150-002 WAKIX EQ 17.8MG BASE TABLET / ORAL RLD, RS 2019-08-14 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N211150-001 WAKIX EQ 4.45MG BASE TABLET / ORAL RLD 2019-08-14 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N211150-002 WAKIX EQ 17.8MG BASE TABLET / ORAL RLD, RS 2019-08-14 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N211150-001 WAKIX EQ 4.45MG BASE TABLET / ORAL RLD 2019-08-14 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N211150-002 WAKIX EQ 17.8MG BASE TABLET / ORAL RLD, RS 2019-08-14 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N211150-001 WAKIX EQ 4.45MG BASE TABLET / ORAL RLD 2019-08-14 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N211150-002 WAKIX EQ 17.8MG BASE TABLET / ORAL RLD, RS 2019-08-14 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N211150-001 WAKIX EQ 4.45MG BASE TABLET / ORAL RLD 2019-08-14 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N211150-002 WAKIX EQ 17.8MG BASE TABLET / ORAL RLD, RS 2019-08-14 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N211150-001 WAKIX EQ 4.45MG BASE TABLET / ORAL RLD 2019-08-14 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N211150-002 WAKIX EQ 17.8MG BASE TABLET / ORAL RLD, RS 2019-08-14 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N211150-001 WAKIX EQ 4.45MG BASE TABLET / ORAL RLD 2019-08-14 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N211150-002 WAKIX EQ 17.8MG BASE TABLET / ORAL RLD, RS 2019-08-14 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N211150-001 WAKIX EQ 4.45MG BASE TABLET / ORAL RLD 2019-08-14 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N211150-002 WAKIX EQ 17.8MG BASE TABLET / ORAL RLD, RS 2019-08-14 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N211150-001 WAKIX EQ 4.45MG BASE TABLET / ORAL RLD 2019-08-14 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N211150-002 WAKIX EQ 17.8MG BASE TABLET / ORAL RLD, RS 2019-08-14 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N211150-001 WAKIX EQ 4.45MG BASE TABLET / ORAL RLD 2019-08-14 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N211150-002 WAKIX EQ 17.8MG BASE TABLET / ORAL RLD, RS 2019-08-14 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N211150-001 WAKIX EQ 4.45MG BASE TABLET / ORAL RLD 2019-08-14 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N211150-002 WAKIX EQ 17.8MG BASE TABLET / ORAL RLD, RS 2019-08-14 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N211150-001 WAKIX EQ 4.45MG BASE TABLET / ORAL RLD 2019-08-14 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N211150-002 WAKIX EQ 17.8MG BASE TABLET / ORAL RLD, RS 2019-08-14 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N211150-001 WAKIX EQ 4.45MG BASE TABLET / ORAL RLD 2019-08-14 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N211150-002 WAKIX EQ 17.8MG BASE TABLET / ORAL RLD, RS 2019-08-14 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N211150-001 WAKIX EQ 4.45MG BASE TABLET / ORAL RLD 2019-08-14 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N211150-002 WAKIX EQ 17.8MG BASE TABLET / ORAL RLD, RS 2019-08-14 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N211150-001 WAKIX EQ 4.45MG BASE TABLET / ORAL RLD 2019-08-14 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N211150-002 WAKIX EQ 17.8MG BASE TABLET / ORAL RLD, RS 2019-08-14 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N211150-001 WAKIX EQ 4.45MG BASE TABLET / ORAL RLD 2019-08-14 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N211150-002 WAKIX EQ 17.8MG BASE TABLET / ORAL RLD, RS 2019-08-14 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N211150-001 WAKIX EQ 4.45MG BASE TABLET / ORAL RLD 2019-08-14 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N211150-002 WAKIX EQ 17.8MG BASE TABLET / ORAL RLD, RS 2019-08-14 74a2ff9319b5…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 11 · 420 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N211150-001 8354430 2026-02-06 U-1101 2019-09-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211150-001 8354430 2026-02-06 U-1102 2019-09-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211150-001 8486947 2029-09-26 U-1101 2019-09-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211150-001 8486947 2029-09-26 U-1102 2019-09-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211150-001 8207197 2030-03-07 Drug substance, Drug product 2019-09-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211150-002 8354430 2026-02-06 U-1101 2019-09-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211150-002 8354430 2026-02-06 U-1102 2019-09-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211150-002 8486947 2029-09-26 U-1101 2019-09-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211150-002 8486947 2029-09-26 U-1102 2019-09-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211150-002 8207197 2030-03-07 Drug substance, Drug product 2019-09-11 84e616aacf4f…2026-08-18 06:07:40 2026-07 N211150-001 8354430 2026-02-06 U-1101 2019-09-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211150-001 8354430 2026-02-06 U-1102 2019-09-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211150-001 8486947 2029-09-26 U-1101 2019-09-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211150-001 8486947 2029-09-26 U-1102 2019-09-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211150-001 8207197 2030-03-07 Drug substance, Drug product 2019-09-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211150-002 8354430 2026-02-06 U-1101 2019-09-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211150-002 8354430 2026-02-06 U-1102 2019-09-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211150-002 8486947 2029-09-26 U-1101 2019-09-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211150-002 8486947 2029-09-26 U-1102 2019-09-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211150-002 8207197 2030-03-07 Drug substance, Drug product 2019-09-11 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N211150-001 8354430 2026-02-06 U-1101 2019-09-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211150-001 8354430 2026-02-06 U-1102 2019-09-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211150-001 8486947 2029-09-26 U-1101 2019-09-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211150-001 8486947 2029-09-26 U-1102 2019-09-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211150-001 8207197 2030-03-07 Drug substance, Drug product 2019-09-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211150-002 8354430 2026-02-06 U-1101 2019-09-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211150-002 8354430 2026-02-06 U-1102 2019-09-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211150-002 8486947 2029-09-26 U-1101 2019-09-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211150-002 8486947 2029-09-26 U-1102 2019-09-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211150-002 8207197 2030-03-07 Drug substance, Drug product 2019-09-11 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211150-001 8354430 2026-02-06 U-1101 2019-09-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211150-001 8354430 2026-02-06 U-1102 2019-09-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211150-001 8486947 2029-09-26 U-1101 2019-09-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211150-001 8486947 2029-09-26 U-1102 2019-09-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211150-001 8207197 2030-03-07 Drug substance, Drug product 2019-09-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211150-002 8354430 2026-02-06 U-1101 2019-09-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211150-002 8354430 2026-02-06 U-1102 2019-09-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211150-002 8486947 2029-09-26 U-1101 2019-09-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211150-002 8486947 2029-09-26 U-1102 2019-09-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211150-002 8207197 2030-03-07 Drug substance, Drug product 2019-09-11 31067a03dcf5…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 8 · 318 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 14 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 72028-045 Wakix PITOLISANT HYDROCHLORIDE Harmony Biosciences, LLC NDA Current 72028-045 Wakix PITOLISANT HYDROCHLORIDE Harmony Biosciences, LLC NDA Current 72028-045 Wakix PITOLISANT HYDROCHLORIDE Harmony Biosciences, LLC NDA Current 72028-045 Wakix PITOLISANT HYDROCHLORIDE Harmony Biosciences, LLC NDA Current 72028-045 Wakix PITOLISANT HYDROCHLORIDE Harmony Biosciences, LLC NDA Current 72028-045 Wakix PITOLISANT HYDROCHLORIDE Harmony Biosciences, LLC NDA Current 72028-045 Wakix PITOLISANT HYDROCHLORIDE Harmony Biosciences, LLC NDA Current 72028-178 Wakix PITOLISANT HYDROCHLORIDE Harmony Biosciences, LLC NDA Current 72028-178 Wakix PITOLISANT HYDROCHLORIDE Harmony Biosciences, LLC NDA Current 72028-178 Wakix PITOLISANT HYDROCHLORIDE Harmony Biosciences, LLC NDA Current 72028-178 Wakix PITOLISANT HYDROCHLORIDE Harmony Biosciences, LLC NDA Current 72028-178 Wakix PITOLISANT HYDROCHLORIDE Harmony Biosciences, LLC NDA Current 72028-178 Wakix PITOLISANT HYDROCHLORIDE Harmony Biosciences, LLC NDA Current 72028-178 Wakix PITOLISANT HYDROCHLORIDE Harmony Biosciences, LLC NDA Current